vs
agilon health, inc.（AGL）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是罗致恒富的1.2倍（$1.6B vs $1.3B），agilon health, inc.同比增速更快（3.1% vs -5.8%），罗致恒富自由现金流更多（$170.8M vs $-23.5M），过去两年agilon health, inc.的营收复合增速更高（-1.1% vs -6.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
AGL vs RHI — 直观对比
营收规模更大
AGL
是对方的1.2倍
$1.3B
营收增速更快
AGL
高出8.9%
-5.8%
自由现金流更多
RHI
多$194.3M
$-23.5M
两年增速更快
AGL
近两年复合增速
-6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.3B |
| 净利润 | $-188.9M | — |
| 毛利率 | — | 37.6% |
| 营业利润率 | -12.3% | 1.7% |
| 净利率 | -12.0% | — |
| 营收同比 | 3.1% | -5.8% |
| 净利润同比 | -78.5% | — |
| 每股收益（稀释后） | — | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRHI
| Q4 25 | $1.6B | $1.3B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.5B | $1.4B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.5B | ||
| Q1 24 | $1.6B | $1.5B |
净利润AGLRHI
| Q4 25 | $-188.9M | — | ||
| Q3 25 | $-110.2M | $42.9M | ||
| Q2 25 | $-104.4M | $41.0M | ||
| Q1 25 | $12.1M | $17.4M | ||
| Q4 24 | $-105.8M | — | ||
| Q3 24 | $-117.6M | $65.5M | ||
| Q2 24 | $-30.7M | $68.2M | ||
| Q1 24 | $-6.1M | $63.7M |
毛利率AGLRHI
| Q4 25 | — | 37.6% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | — | 37.2% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | — | 38.8% | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | — | 39.2% | ||
| Q1 24 | — | 38.1% |
营业利润率AGLRHI
| Q4 25 | -12.3% | 1.7% | ||
| Q3 25 | -9.1% | 1.0% | ||
| Q2 25 | -8.3% | 0.1% | ||
| Q1 25 | -1.4% | 2.9% | ||
| Q4 24 | -7.1% | 4.7% | ||
| Q3 24 | -9.2% | 4.1% | ||
| Q2 24 | -2.9% | 5.1% | ||
| Q1 24 | -0.4% | 2.8% |
净利率AGLRHI
| Q4 25 | -12.0% | — | ||
| Q3 25 | -7.7% | 3.2% | ||
| Q2 25 | -7.5% | 3.0% | ||
| Q1 25 | 0.8% | 1.3% | ||
| Q4 24 | -6.9% | — | ||
| Q3 24 | -8.1% | 4.5% | ||
| Q2 24 | -2.1% | 4.6% | ||
| Q1 24 | -0.4% | 4.3% |
每股收益（稀释后）AGLRHI
| Q4 25 | — | $0.32 | ||
| Q3 25 | — | $0.43 | ||
| Q2 25 | — | $0.41 | ||
| Q1 25 | — | $0.17 | ||
| Q4 24 | — | $0.53 | ||
| Q3 24 | — | $0.64 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $464.4M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $1.3B |
| 总资产 | $1.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLRHI
| Q4 25 | $173.7M | $464.4M | ||
| Q3 25 | $171.7M | $365.3M | ||
| Q2 25 | $171.4M | $380.5M | ||
| Q1 25 | $136.9M | $342.5M | ||
| Q4 24 | $188.2M | $537.6M | ||
| Q3 24 | $148.2M | $570.5M | ||
| Q2 24 | $109.5M | $547.4M | ||
| Q1 24 | $111.7M | $540.9M |
总债务AGLRHI
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGLRHI
| Q4 25 | $126.7M | $1.3B | ||
| Q3 25 | $306.1M | $1.3B | ||
| Q2 25 | $408.9M | $1.3B | ||
| Q1 25 | $500.3M | $1.3B | ||
| Q4 24 | $471.0M | $1.4B | ||
| Q3 24 | $574.9M | $1.5B | ||
| Q2 24 | $676.6M | $1.5B | ||
| Q1 24 | $689.3M | $1.5B |
总资产AGLRHI
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.6B | $2.8B | ||
| Q2 25 | $1.7B | $2.8B | ||
| Q1 25 | $1.9B | $2.7B | ||
| Q4 24 | $1.7B | $2.9B | ||
| Q3 24 | $2.1B | $3.0B | ||
| Q2 24 | $2.2B | $2.9B | ||
| Q1 24 | $2.3B | $2.9B |
负债/权益比AGLRHI
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $170.8M |
| 自由现金流率自由现金流/营收 | -1.5% | 13.1% |
| 资本支出强度资本支出/营收 | 0.2% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $266.8M |
8季度趋势，按日历期对齐
经营现金流AGLRHI
| Q4 25 | $-20.5M | $182.5M | ||
| Q3 25 | $-18.2M | $77.4M | ||
| Q2 25 | $-35.1M | $119.4M | ||
| Q1 25 | $-32.0M | $-59.3M | ||
| Q4 24 | $16.4M | $154.8M | ||
| Q3 24 | $-7.7M | $129.6M | ||
| Q2 24 | $-18.7M | $142.0M | ||
| Q1 24 | $-47.8M | $-15.9M |
自由现金流AGLRHI
| Q4 25 | $-23.5M | $170.8M | ||
| Q3 25 | $-21.3M | $63.6M | ||
| Q2 25 | $-38.3M | $104.2M | ||
| Q1 25 | $-35.8M | $-71.7M | ||
| Q4 24 | $13.2M | $140.5M | ||
| Q3 24 | $-11.2M | $111.8M | ||
| Q2 24 | $-22.0M | $129.6M | ||
| Q1 24 | $-50.9M | $-27.7M |
自由现金流率AGLRHI
| Q4 25 | -1.5% | 13.1% | ||
| Q3 25 | -1.5% | 4.7% | ||
| Q2 25 | -2.7% | 7.6% | ||
| Q1 25 | -2.3% | -5.3% | ||
| Q4 24 | 0.9% | 10.2% | ||
| Q3 24 | -0.8% | 7.6% | ||
| Q2 24 | -1.5% | 8.8% | ||
| Q1 24 | -3.2% | -1.9% |
资本支出强度AGLRHI
| Q4 25 | 0.2% | 0.9% | ||
| Q3 25 | 0.2% | 1.0% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.3% | 0.9% | ||
| Q4 24 | 0.2% | 1.0% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.2% | 0.8% | ||
| Q1 24 | 0.2% | 0.8% |
现金转化率AGLRHI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | — | 2.91× | ||
| Q1 25 | -2.64× | -3.42× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.08× | ||
| Q1 24 | — | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
